Repositioning Candidate Details
| Candidate ID: | R0970 |
| Source ID: | DB06276 |
| Source Type: | investigational |
| Compound Type: | small molecule |
| Compound Name: | Tanomastat |
| Synonyms: | Tanomastat |
| Molecular Formula: | C23H19ClO3S |
| SMILES: | OC(=O)[C@@H](CSC1=CC=CC=C1)CC(=O)C1=CC=C(C=C1)C1=CC=C(Cl)C=C1 |
| Structure: |
|
| DrugBank Description: | -- |
| CAS Number: | 179545-77-8 |
| Molecular Weight: | 410.91 |
| DrugBank Indication: | Investigated for use/treatment in pancreatic cancer, lung cancer, ovarian cancer, and osteoarthritis. |
| DrugBank Pharmacology: | -- |
| DrugBank MoA: | -- |
| Targets: | -- |
| Inclusion Criteria: | Indication associated |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class | |
|---|---|---|---|---|---|
| I15 | 1290 | Bone disease | A connective tissue disease that affects the structure or development of bone or causes an impairment of normal bone function. http://en.wikipedia.org/wiki/Bone_disease | disease of anatomical entity/ musculoskeletal system disease/connective tissue disease | Details |